Welcome to Onco Healthmart!

Emcure Pharmaceuticals Ltd

Salt: Tacrolimus (1mg)

Prescription Required: Yes
See Similar Products

Vingraf 1mg Capsule

MRP: ₹431.22       Discount: 36%
Sale Price:

₹280.00


Vingraf 1 Capsule is used along with other medicines to prevent your body from rejecting a new organ (e.g., liver, kidney, or heart) after transplant. It does so by weakening your body’s immune system, so it does not attack the new organ. This medication belongs to a class of drugs known as immunosuppressants.

Add to Cart

Weight/Quantity: 10 CAPSULE(s) IN A STRIP

Store below 30°C

Vingraf 1 Capsule is used along with other medicines to prevent your body from rejecting a new organ (e.g., liver, kidney, or heart) after transplant. It does so by weakening your body’s immune system, so it does not attack the new organ. This medication belongs to a class of drugs known as immunosuppressants.
In Prevention of organ rejection in transplant patients
Vingraf 1 Capsule belongs to a group of medicines known as immunosuppressants. Organ rejection happens when your immune system treats the new organ as an invader and attacks it. This medicine weakens your immune response (which usually fights infection) and reduces the chance of your body attacking the transplanted organ. It is used in combination with other medicines to make it much more likely that your transplant operation will be successful. You should continue taking the medicine and should not stop it until your doctor says so.
Take this medicine in the dose and duration as advised by your doctor.
Take this medicine in the dose and duration as advised by your doctor.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Vingraf
Diarrhea
Increased glucose level in blood
Increased thirst
Kidney damage
Liver damage
Nausea
Stomach pain

Similar Products


©2023 Onco Healthmart. All Rights Reserved. Powered by Hover Business Services LLP.